Featured sources, June 13
Featured sources for the week of June 13 include vaccine distribution by Congressional districts, fiscal accountability for COVID-19 responses, and risk levels for kids.
Read MoreTag: vaccine distribution
25 million doses is a drop in the global vaccination bucket
On Thursday, the Biden administration made a big (and long-awaited) announcement: the federal government is sending 25 million vaccine doses from America’s stockpile to other countries.25 million doses—or even the 80 million doses that the administration has promised by the end of this month—is a drop in the bucket compared to actual international needs. For example: COVAX needs 1.8 billion doses to vaccinate about half the adult population in low-income countries. COVAX has specifically prioritized 92 low-income nations, representing a total population of 3.8 billion.
Read MoreThe CDC needs to release state-by-state data on who’s getting vaccinated
This week, we finally got demographic state-by-state vaccination data from the CDC. Well… sort-of. A team from KHN received CDC state-by-state demographic vaccination data via a public records request. The data indicate that, despite promises from the White House to prioritize vulnerable communities in the vaccination campaign, a lot of inequities persist.
Read MoreCOVID source shoutout: Unique vaccine metrics
Most states report some variation on the same COVID-19 vaccination metrics: doses allocated, doses administered, state residents who’ve been partially and fully vaccinated, and so on. But some states go beyond those basics.
Read Morethere might be a link between the Oxford-AstraZeneca vaccine and those blood clots after all
This week, authorities had enough data to posit a possible connection between blood clots known as cerebral venous sinus thrombosis (CVST) and the Oxford-AstraZeneca vaccine. The EMA has now advised, as of April 7, that “that unusual blood clots with low blood platelets should be listed as very rare side effects of Vaxzevria (formerly COVID-19 Vaccine AstraZeneca).” They are still recommending its use given the gravity of the COVID-19 pandemic, but it’s another blow to the vaccine that held much of the world’s hopes in inoculating the entire population. A mechanism by which the vaccine is causing these thromboses has not been discovered.
Read MoreFeatured sources, April 4
Featured sources for the week of April 4 include updates on state vaccination data, mortality data, vaccine trials, and healthcare.
Read MoreWhat the hell is going on with the Oxford-AstraZeneca vaccine?
The problem child of COVID-19 vaccines was back in the news this week. After South Africa suspended the Oxford-AstraZeneca vaccine’s use when it failed to slow the spread of the predominant B.1.351 variant, vaccination using this vaccine has been suspended and then resumed in many European countries following reports of blood clots in some people who received it.
Read MoreFeatured sources, March 7
Featured sources for the week of March 7 include variants, public documents, and vaccination sites.
Read MoreFeatured sources and federal data updates, Feb. 28
Featured sources and federal updates for the week of Feb. 28 include vaccines, the CDC’s methodology, school opening, and more.
Read MoreNext in vaccination data demands: some, oh god, just any occupational data
Not a single state reports out vaccination by occupation.
Read More